Telangiectasia: Clinical Trials

3 trials for Telangiectasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Telangiectasia: new trials by email Literature Review of Telangiectasia trials Research Report on Telangiectasia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Ranibizumab - Telangiectasia
Phase 1CompletedNational Eye Institute (NEI)52007-03-272017-07-02
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
Ranibizumab - Telangiectasia
Phase 1CompletedNational Eye Institute (NEI)52007-03-272017-07-02
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
Ranibizumab - Telangiectasia
Phase 1CompletedJohns Hopkins University102006-09-012012-11-14

Narrower conditions

Telangiectasis (3)  ·  Idiopathic Juxtafoveal Retinal Telangiectasia (2)  ·  Papilledema (2)

Broader conditions

Cardiovascular Diseases (3)  ·  Vascular Diseases (3)  ·  Cranial Nerve Diseases (2)  ·  Eye Diseases (2)  ·  Nervous System Diseases (2)  ·  Optic Nerve Diseases (2)

Interventions

Ranibizumab (3)

Sponsors

National Eye Institute (NEI) (2)  ·  Johns Hopkins University (1)

Countries

United States (3)

Top investigators

Neil M. Bressler, MD (1)